B-Cell Non-Hodgkin Lymphoma
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Swedish Orphan BiovitrumAnakinra
ADC TherapeuticsLoncastuximab Tesirine
Clinical Trials (2)
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
Start: Dec 2021Est. completion: Dec 2024
Phase 2Completed
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Start: Jun 2022Est. completion: Oct 2027
Phase 1Recruiting
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
5h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
7h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
2 companies competing in this space